"We have generated significant interest from pharmaceutical partners in the HA-Irinotecan program and our licensing discussions are currently underway with multiple parties."
In their presentation 2014 key activities is stating potential partnership. I take it that these companies are probably willing to wait for the TOP-LINE data before signing a mind blowing deal :-)
Again they have mentioned potential monetization of Fonda, it would be nice if someone coming from the AGM can tell us what they meant by monetization just to be clear.
Ann: Chairman's Address to Shareholders , page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable